Results 321 to 330 of about 94,528 (347)

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Peter Schellongowski   +2 more
exaly  

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Carl M Gay, Helmut H Popper, Robert Pirker   +2 more
exaly  

Adoptive Cell Therapy for Pediatric Solid Tumors

Cold Spring Harbor Perspectives in Medicine
Patients with relapsed or refractory pediatric solid tumors have limited therapeutic options with little to no appreciable improvements in outcomes in over two decades. Adoptive cell therapy (ACT) is a promising, targeted option for patients with the potential to minimize acute and long-term toxicities.
Amy B, Hont, Catherine M, Bollard
openaire   +2 more sources

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul Parikh, Sagar Lonial
exaly  

Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells

Cancer Cell, 2021
Guangxu Jin, Xiaoyin Li, Qing Yi
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Recent advances in biomaterial-boosted adoptive cell therapy

Chemical Society Reviews, 2022
Yonger Xue, Xiaoyuan Chen, Jinbing Xie
exaly  

Adoptive cell therapy for glioma

2022
Lan B. Hoang-Minh, Duane A. Mitchell
openaire   +1 more source

Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in Melanoma

Immunity, 2020
Maike Effern, Nicole Glodde, Emma Bawden
exaly  

Adoptive T-cell therapy for CMV

Cytotherapy, 2002
openaire   +2 more sources